CARTER-WALLACE ORGANIDIN CONSENT DECREE WITH FDA
Executive Summary
CARTER-WALLACE ORGANIDIN CONSENT DECREE WITH FDA calls for the company to "discontinue the manufacture and shipment of its Organidin (iodinated glycerol) line of products," Carter-Wallace said June 27. "The agreement between the company and FDA does not prohibit the continued shipping, prescribing and dispensing of existing stocks of Organidin product already in distribution channels," the company added.